339317-22-5Relevant academic research and scientific papers
SYNTHETIC INNATE IMMUNE RECEPTOR LIGANDS AND USES THEREOF
-
Paragraph 0059; 00108, (2020/06/10)
An adjuvant formulation includes a monophosphoryl Lipid A (MPLA) analogue, a Pam3CSK4 analogue, or a muramyldipeptide (MDP) analogue, or combinations thereof. The adjuvant may be formulated in soluble form or in a nanoparticle, such as polylactic glycolic acid nanoparticles. A vaccine formulation comprises the adjuvant formulation and an immunogen. Methods of vaccinating an animal include delivering the vaccine formulation to the animal.
Novel lipid A mimetics derived from pentaerythritol: Synthesis and their potent agonistic activity
Jiang, Zi-Hua,Budzynski, Wladyslaw A,Skeels, Lisa N,Krantz, Mark J,Koganty, R.Rao
, p. 8833 - 8842 (2007/10/03)
A pentaerythritol unit is substituted for glucosamine as its functional mimic at the reducing end of lipid A disaccharide. Two such pentaerythritol derived lipid A mimetics 3 and 4, carrying three identical fatty acyl moieties, have been designed and synt
